Neuroinflammation and the dynamic lesion in traumatic brain injury

Department of Psychology and Neuroscience Centre, 1001 SWKT, Brigham Young University, Provo, UT 84602, USA. .
Brain (Impact Factor: 9.2). 01/2013; 136(Pt 1):9-11. DOI: 10.1093/brain/aws342
Source: PubMed
2 Reads
    • "Continued myelin degeneration ( Meythaler et al . , 2001 ) , chronic neuroinflammation ( Bigler , 2013a , 2013b ; Johnson et al . , 2013 ) and Wallerian degeneration as a result of axonal disconnection ( Bendlin et al . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in neuroimaging methodologies sensitive to axonal injury have made it possible to assess in vivo the extent of traumatic brain injury (TBI) -related disruption in neural structures and their connections. The objective of this paper is to review studies examining connectivity in TBI with an emphasis on structural and functional MRI methods that have proven to be valuable in uncovering neural abnormalities associated with this condition. We review studies that have examined white matter integrity in TBI of varying etiology and levels of severity, and consider how findings at different times post-injury may inform underlying mechanisms of post-injury progression and recovery. Moreover, in light of recent advances in neuroimaging methods to study the functional connectivity among brain regions that form integrated networks, we review TBI studies that use resting-state functional connectivity MRI methodology to examine neural networks disrupted by putative axonal injury. The findings suggest that TBI is associated with altered structural and functional connectivity, characterized by decreased integrity of white matter pathways and imbalance and inefficiency of functional networks. These structural and functional alterations are often associated with neurocognitive dysfunction and poor functional outcomes. TBI has a negative impact on distributed brain networks that lead to behavioral disturbance.
    Journal of the International Neuropsychological Society 11/2015; in press. · 2.96 Impact Factor
  • Source
    • "After the experiment, the cultures were fixed in 4% paraformaldehyde and permeated using 0.2% Triton X-100 in PBS for 10 min, as previously described [23], [25]. The background staining was reduced by blocking nonspecific binding sites with 10% goat serum for 1 h at RT. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In response to acute insults to the central nervous system, such as pathogen invasion or neuronal injuries, glial cells become activated and secrete inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines. This neuroinflammation plays a crucial role in the pathophysiology of chronic neurodegenerative diseases. Endogenous ascorbate levels are significantly decreased among patients with septic encephalopathy. Using the bacterial endotoxin lipopolysaccharide (LPS) to induce neuroinflammation in primary neuron/glia cocultures, we investigated how L-ascorbate (vitamin C; Vit. C) affected neuroinflammation. LPS (100 ng/ml) induced the expression of inducible NO synthase (iNOS) and the production of NO, interleukin (IL)-6, and macrophage inflammatory protein-2 (MIP-2/CXCL2) in a time-dependent manner; however, cotreatment with Vit. C (5 or 10 mM) attenuated the LPS-induced iNOS expression and production of NO, IL-6, and MIP-2 production. The morphological features revealed after immunocytochemical staining confirmed that Vit. C suppressed LPS-induced astrocytic and microglial activation. Because Vit. C can be transported into neurons and glia via the sodium-dependent Vit. C transporter-2, we examined how Vit. C affected LPS-activated intracellular signaling in neuron/glia cocultures. The results indicated the increased activation (caused by phosphorylation) of mitogen-activated protein kinases (MAPKs), such as p38 at 30 min and extracellular signal-regulated kinases (ERKs) at 180 min after LPS treatment. The inhibition of p38 and ERK MAPK suppressed the LPS-induced production of inflammatory mediators. Vit. C also inhibited the LPS-induced activation of p38 and ERK. Combined treatments of Vit. C and the inhibitors of p38 and ERK yielded no additional inhibition compared with using the inhibitors alone, suggesting that Vit. C functions through the same signaling pathway (i.e., MAPK) as these inhibitors. Vit. C also reduced LPS-induced IκB-α degradation and NF-κB translocation. Thus, Vit. C suppressed the LPS-stimulated production of inflammatory mediators in neuron/glia cocultures by inhibiting the MAPK and NF-κB signaling pathways.
    PLoS ONE 07/2014; 9(7):e97276. DOI:10.1371/journal.pone.0097276 · 3.23 Impact Factor
  • Source
    • "While these effects can be accounted for by acute/sub-acute injury mechanisms and their pathological consequences, given the above observations, neuroinflammatory and neurodegenerative processes may extend for years beyond the initial post-injury injury time frame in the TBI patient. These more chronic effects do set the stage for important interactions that occur between the age at the time of injury, aging and age-related vulnerabilities, to later in life neuropsychiatric and progressive neurodegenerative disorders indicating that the lesion in TBI may be much more dynamic (Bigler, 2013). The frontotemporolimbic locus of where TBI induced degenerative changes are most likely to occur in the brain, has a most interesting overlap with brain areas observed in older individuals with increased risk for a variety of age-related neurological and neuropsychiatric disorders. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Depending on severity, traumatic brain injury (TBI) induces immediate neuropathological effects that in the mildest form may be transient but as severity increases results in neural damage and degeneration. The first phase of neural degeneration is explainable by the primary acute and secondary neuropathological effects initiated by the injury; however, neuroimaging studies demonstrate a prolonged period of pathological changes that progressively occur even during the chronic phase. This review examines how neuroimaging may be used in TBI to understand (1) the dynamic changes that occur in brain development relevant to understanding the effects of TBI and how these relate to developmental stage when the brain is injured, (2) how TBI interferes with age-typical brain development and the effects of aging thereafter, and (3) how TBI results in greater frontotemporolimbic damage, results in cerebral atrophy, and is more disruptive to white matter neural connectivity. Neuroimaging quantification in TBI demonstrates degenerative effects from brain injury over time. An adverse synergistic influence of TBI with aging may predispose the brain injured individual for the development of neuropsychiatric and neurodegenerative disorders long after surviving the brain injury.
    Frontiers in Human Neuroscience 08/2013; 7:395. DOI:10.3389/fnhum.2013.00395 · 3.63 Impact Factor
Show more